Traceable platinum(II) complexes with alkylene diamine-derived ligands: synthesis, characterization and in vitro studies

Abstract

Diiodido- (6a/6b) and dichloridoplatinum(II) complexes (7a/7b) with fluorescent ligands 2-[(2-aminoethyl)amino]ethyl-2-(methylamino)benzoate (5a) and 2-amino-1-(aminoethyl)ethyl-2-(methylamino)benzoate (5b) were prepared and characterized by elemental analysis, ESI-MS analysis, fluorescence spectrometry, as well as ¹H, ¹³C, and ¹⁹⁵Pt NMR spectroscopy. All compounds have been tested against A2780 ovarian cancer, A549 lung carcinoma, and HT-29 colon cancer cell lines using sulforhodamine-B assay. The activity increased from ligand precursors, diiodido- to dichloridoplatinum(II) complexes, except against HT-29 cell line where diiodido and dichlorido expressed similar activity. These compounds enter the tumor cells and emit a bright fluorescence at ca. 470 nm, mainly targeting nuclei.

Keywords:

• Cisplatin
• platinum(II) complexes
• cytotoxicity
• fluorescence

Acknowledgements

We thank Prof Dr S. Mijatović and Prof Dr D. Maksimović-Ivanić for helpful discussion.